Stylianos O.
- Country
- Greece
- Department
- 1st Intensive Care Clinic
Research Overview
Data & Insights
Has run more than one trial at 40 of 42 partner sites.
Specializations
Pulmonary Vascular Research
This investigator specializes in treating and researching Pulmonary Arterial Hypertension (PAH), focusing on innovative therapeutic approaches through inhalation-based treatments. Their work examines the effectiveness of novel drug delivery methods in managing pulmonary vascular conditions.
- Pulmonary vascular resistance assessment
- Right heart catheterization techniques
- Exercise capacity evaluation
The research encompasses comprehensive evaluation of cardiopulmonary parameters and biomarkers in PAH patients.
Clinical Assessment Methods
The investigator employs advanced clinical assessment techniques including right heart catheterization and 6-minute walk distance (6MWD) testing to evaluate treatment efficacy in pulmonary hypertension.
- Cardiac biomarker analysis
- Echocardiographic assessment
- Long-term safety monitoring
Their work involves comprehensive evaluation of both immediate and extended treatment outcomes in vascular medicine.
Therapeutic Innovation
The investigator focuses on developing and evaluating inhaled therapeutic solutions for pulmonary vascular diseases, particularly exploring novel drug delivery systems for treating PAH.
- Dose optimization studies
- Treatment safety assessment
- Long-term efficacy monitoring
Their research extends to examining sustained therapeutic effects and safety profiles in extended treatment protocols.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.